🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Castleman Disease

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease NCT05907759Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Daratumumab SC Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS) NCT06052618Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Pacritinib New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease NCT07793006NA1 site📍 Lilongwe Indiana University · Tests: Lymph Node or Core Needle Biopsy, Fine Needle Aspiration, Tiny Isothermal Nucleic acid Amplification System (TINY) A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH NCT05283993n/a1 site📍 Beijing Peking University First Hospital · Tests: No intervention Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers NCT05663502n/a8 sites📍 La Jolla📍 San Francisco📍 Washington D.C. AIDS Malignancy Consortium · Tests: Biospecimen Collection AutoInflammatory Disease Alliance Registry (AIDA) NCT05200715n/a112 sites📍 Algiers📍 Boumerdas📍 Adelaide University of Siena · Tests: No intervention is foreseen by the protocol. International Registry for Patients With Castleman Disease NCT02817997n/a1 site📍 Philadelphia University of Pennsylvania Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease NCT03300830n/a1 site📍 Bethesda National Cancer Institute (NCI) Registry for Adults With Plasma Cell Disorders (PCD's) NCT03717844n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center Natural History of KSHV-Associated Multicentric Castleman s Disease NCT04968288n/a1 site📍 Bethesda National Cancer Institute (NCI) Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease NCT07085039Phase 21 site📍 Philadelphia University of Pennsylvania · Tests: Ruxolitinib Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer NCT00006518n/a1 site📍 Bethesda National Cancer Institute (NCI) An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context NCT06720870n/a12 sites📍 Bologna📍 Caserta📍 Bari IRCCS Azienda Ospedaliero-Universitaria di Bologna Phase III Trial of VDJ001 In Patients With Idiopathic Multicentric Castleman Disease NCT07872423Phase 38 sites📍 Beijing📍 Xiamen📍 Wuhan Beijing VDJBio Co., LTD. · Tests: Recombinant Humanized Anti-Interleukin-6 Receptor Monoclonal Antibody Injection, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy